Imunon, Inc. Cash And Cash Equivalents At Carrying Value

• Imunon, Inc. showed an increase of +49.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from Imunon, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), Imunon, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 26.8%.
• Historical annual values: Fiscal year 2025: $8.78 million | Fiscal year 2024: $5.87 million | Fiscal year 2023: $5.84 million | Fiscal year 2022: $11.49 million | Fiscal year 2021: $19.59 million | Fiscal year 2020: $17.16 million | Fiscal year 2019: $6.88 million | Fiscal year 2018: $13.35 million | Fiscal year 2017: $11.44 million | Fiscal year 2016: $2.62 million | Fiscal year 2015: $9.27 million | Fiscal year 2014: $12.69 million | Fiscal year 2013: $5.72 million | Fiscal year 2012: $14.99 million | Fiscal year 2011: $20.15 million | Fiscal year 2010: $1.14 million | Fiscal year 2009: $6.92 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026